We are live on ! Find out more
OSCR icon

Oscar Health

132 hedge funds and large institutions have $342M invested in Oscar Health in 2022 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 47 increasing their positions, 28 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

638% more call options, than puts

Call options by funds: $1.15M | Put options by funds: $156K

68% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 28

7% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 27

1% less funds holding

Funds holding: 133132 (-1)

4.41% less ownership

Funds ownership: 82.95%78.54% (-4.4%)

33% less funds holding in top 10

Funds holding in top 10: 96 (-3)

53% less capital invested

Capital invested by funds: $733M → $342M (-$391M)

Holders
132
Holders Change
-1
Holders Change %
-0.75%
% of All Funds
2.12%
Holding in Top 10
6
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-33.33%
% of All Funds
0.1%
New
29
Increased
47
Reduced
28
Closed
27
Calls
$1.15M
Puts
$156K
Net Calls
+$996K
Net Calls Change
-$955K

OSCR Hedge Fund Activity: Q4 2022 in Review

132 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Oscar Health (OSCR) for Q4 2022, worth a combined $342M — down 53% from $733M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new OSCR positions and 27 closed out — a net gain of 2 holders — while 47 added to existing stakes and 28 trimmed.

The largest buyer was BlackRock, adding an estimated $12M. The largest seller was Baillie Gifford & Co, cutting an estimated $60.2M.

  • 132 institutional investors held Oscar Health (OSCR) as of Q4 2022, down from 133 in Q3 2022.
  • Funds reported $342M of Oscar Health stock for Q4 2022, down 53% quarter-over-quarter.
  • 29 funds opened new Oscar Health positions in Q4 2022 and 27 closed out, a net change of +2 holders.
  • The largest Oscar Health buyer in Q4 2022 was BlackRock, an estimated $12M added.
  • The largest Oscar Health seller in Q4 2022 was Baillie Gifford & Co, an estimated $60.2M sold.

Based on aggregated 13F filings for Q4 2022.